MannKind Corp (MNKD)
6.74
-0.28
(-3.99%)
USD |
NASDAQ |
Nov 15, 10:03
MannKind Cash and Short Term Investments (Quarterly): 251.59M for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 251.59M |
| June 30, 2024 | 247.76M |
| March 31, 2024 | 300.73M |
| December 31, 2023 | 295.10M |
| September 30, 2023 | 141.02M |
| June 30, 2023 | 144.35M |
| March 31, 2023 | 166.14M |
| December 31, 2022 | 170.85M |
| September 30, 2022 | 165.05M |
| June 30, 2022 | 154.16M |
| March 31, 2022 | 162.45M |
| December 31, 2021 | 204.12M |
| September 30, 2021 | 139.05M |
| June 30, 2021 | 162.49M |
| March 31, 2021 | 276.80M |
| December 31, 2020 | 67.00M |
| September 30, 2020 | 52.40M |
| June 30, 2020 | 63.22M |
| March 31, 2020 | 38.87M |
| December 31, 2019 | 49.88M |
| September 30, 2019 | 50.06M |
| June 30, 2019 | 32.88M |
| March 31, 2019 | 59.29M |
| December 31, 2018 | 71.16M |
| September 30, 2018 | 10.45M |
| Date | Value |
|---|---|
| June 30, 2018 | 26.18M |
| March 31, 2018 | 26.71M |
| December 31, 2017 | 43.95M |
| September 30, 2017 | 20.09M |
| June 30, 2017 | 43.38M |
| March 31, 2017 | 47.98M |
| December 31, 2016 | 22.90M |
| September 30, 2016 | 35.53M |
| June 30, 2016 | 63.73M |
| March 31, 2016 | 27.65M |
| December 31, 2015 | 59.07M |
| September 30, 2015 | 32.93M |
| June 30, 2015 | 107.19M |
| March 31, 2015 | 120.84M |
| December 31, 2014 | 120.84M |
| September 30, 2014 | 172.46M |
| June 30, 2014 | 41.21M |
| March 31, 2014 | 35.76M |
| December 31, 2013 | 70.79M |
| September 30, 2013 | 93.80M |
| June 30, 2013 | 28.53M |
| March 31, 2013 | 28.00M |
| December 31, 2012 | 61.84M |
| September 30, 2012 | 1.765M |
| June 30, 2012 | 31.99M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
38.87M
Minimum
Mar 2020
300.73M
Maximum
Mar 2024
162.65M
Average
162.47M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Mirum Pharmaceuticals Inc | 278.37M |
| NovaBay Pharmaceuticals Inc | 0.776M |
| Palatin Technologies Inc | 9.527M |
| iBio Inc | 14.21M |
| Theriva Biologics Inc | 16.59M |